APPLICATION
Application Note
*Optimal dilutions/concentrations should be determined by the researcher.
Application |
Recommended Dilution |
0.2-2.5 ug/ml |
Not tested in other applications.
Calculated MW
Positive Control
human fetal small intestine
PROPERTIES
Form
Liquid
Buffer
PBS, 2% Sucrose
Preservative
0.09% Sodium azide
Storage
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
Concentration
0.5-1 mg/ml (Please refer to the vial label for the specific concentration.)
Antigen Species
Human
Immunogen
A synthetic peptide corresponding to a N-terminal region of Human HSD17B14
Purification
Affinity Purified
Conjugation
Unconjugated
Note
For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.
TARGET
Synonyms
hydroxysteroid 17-beta dehydrogenase 14 , DHRS10 , SDR47C1 , retSDR3
Cellular Localization
Cytoplasm
Background
17-beta-hydroxysteroid dehydrogenases, such as HSD17B14, are primarily involved in metabolism of steroids at the C17 position and also of other substrates, such as fatty acids, prostaglandins, and xenobiotics (Lukacik et al., 2007 [PubMed 17067289]).[supplied by OMIM, Jun 2009]
Database
Research Area
DATA IMAGES
|
GTX45015 WB Image
WB analysis of human fetal small intestine tissue using GTX45015 HSD17B14 antibody at 0.2-1μg/ml.
|
REFERENCE
There are currently no references for HSD17B14 antibody, N-term (GTX45015). Be the first to share your publications with this product.
REVIEW
There are currently no reviews for HSD17B14 antibody, N-term (GTX45015). Be the first to share your experience with this product.